Kurian Thomas 4

4 · ORACLE CORP · Filed May 2, 2018

Form 4

Period: 2018-04-30

EVP-Product Development

Transactions

Exercise/Conversion
Common Stock
2018-04-30$40.36/sh+57,155$2,306,776→ 80,138 total
Sale
Common Stock
2018-04-30$46.00/sh−57,155$2,629,159→ 22,983 total
Exercise/Conversion
Stock Option
2018-04-30−57,155→ 1,279,402 total
Exercise: $40.36Exp: 2025-07-02→ Common Stock (57,155 underlying)
Award
Performance Stock Unit
2018-05-01+3,473.277→ 843,457.882 total
Exercise: $0.00→ Common Stock (3,473.277 underlying)

Footnotes (3)

[F1]This transaction was executed in multiple trades at prices ranging from $46.00 to $46.0050. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
[F2]Options vest 25% annually on anniversary of grant date.
[F3]Represents dividend equivalents accrued with respect to earned performance stock units the reporting person has elected to defer. The number of dividend equivalents reported was calculated using Oracle's closing stock price on May 1, 2018 ($45.95), the date on which dividends were paid on Oracle's common stock.

Documents

1 file